Guinea vs Kazakhstan: Estimated antiretroviral therapy coverage among people living with HIV
Guinea
80.0%
in 2025
Kazakhstan
79.0%
in 2025
Guinea rank
54th
Kazakhstan rank
57th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Guinea
- Kazakhstan
How they compare
Guinea currently reports 80.0% against 79.0% in Kazakhstan, a difference of 1.0%.
The two have swapped places 5 times across 26 shared years of data; in 2000 it was Kazakhstan ahead.
Guinea ranks 54th and Kazakhstan ranks 57th of 143 countries.
Across the 3 decades both report, Guinea averaged higher in 2 and Kazakhstan in 1.
Head to head by decade
| Decade | Guinea | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.9% | 2.2% | 1.7% | Guinea |
| 2010s | 28.5% | 26.0% | 2.5% | Guinea |
| 2020s | 64.3% | 68.2% | 3.8% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Guinea or Kazakhstan?
- Guinea, at 80.0% against 79.0% in Kazakhstan as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Guinea and Kazakhstan?
- 1.0%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Kazakhstan?
- 26 years are reported by both, from 2000 to 2025.
- How do Guinea and Kazakhstan rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Guinea ranks 54th and Kazakhstan ranks 57th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.